Skip to main content
Top
Published in: Journal of Cancer Survivorship 2/2013

01-06-2013

Employment outcomes among survivors of common cancers: the Symptom Outcomes and Practice Patterns (SOAPP) study

Authors: A. J. Tevaarwerk, J. W. Lee, M. E. Sesto, K. A. Buhr, C. S. Cleeland, J. Manola, L. I. Wagner, V. T. S. Chang, M. J. Fisch

Published in: Journal of Cancer Survivorship | Issue 2/2013

Login to get access

Abstract

Introduction

Risk factors for employment difficulties after cancer diagnosis are incompletely understood, and interventions to improve post-cancer employment remain few. New targets for intervention are needed.

Methods

We assessed a cohort of 530 nonmetastatic cancer patients (aged ≤ 65 years, >6 months from diagnosis, off chemo- or radiotherapy) from the observational multi-site Symptom Outcomes and Practice Patterns study. Participants reported employment change, current employment, and symptoms. Groups were based on employment at survey (working full- or part-time versus not working) and whether there had been a change due to illness (yes versus no). The predictive power of symptom interference with work was evaluated for employment group (working stably versus no longer working). Race/ethnicity, gender, cancer type, therapy, and time since diagnosis were also assessed. Association between employment group and specific symptoms was examined.

Results

The cohort was largely non-Hispanic white (76 %), female (85 %), and diagnosed with breast cancer (75 %); 24 % reported a change in employment. On multivariable analysis, participants with at least moderate symptom interference were more likely to report no longer working than their less effected counterparts (odds ratio (OR) = 8.0, 95 % CI, 4.2–15.4), as were minority participants compared with their non-Hispanic white counterparts (OR = 3.2, 95 % CI, 1.8–5.6). Results from the multiple regression model indicated the combination of fatigue (OR = 2.3, 95 % CI, 1.1–4.7), distress (OR = 3.9, 95 % CI, 1.7–9.0), and dry mouth (OR = 2.6, 95 % CI, 1.1–6.2) together with race/ethnicity and time since diagnosis adequately accounted for employment group.

Conclusions

Our findings support the hypothesis that residual symptom burden is related to post-cancer employment: Residual symptoms may be targets for intervention to improve work outcomes among cancer survivors.

Implications for Cancer Survivors

This analysis examines whether increased symptom burden is associated with a change to not working following a cancer diagnosis. We also examined individual symptoms to assess which symptoms were most strongly associated with not working after a cancer diagnosis. Our hope is that we will be able to use this information to both screen survivors post-active treatment as well as target high-risk symptoms for further and more aggressive intervention, in an attempt to improve post-cancer work outcomes.
Literature
2.
go back to reference Parry C, et al. Cancer survivors: a booming population. Cancer Epidemiol Biomark Prev. 2011;20(10):1996–2005.CrossRef Parry C, et al. Cancer survivors: a booming population. Cancer Epidemiol Biomark Prev. 2011;20(10):1996–2005.CrossRef
3.
go back to reference de Boer AG, et al. Cancer survivors and unemployment: a meta-analysis and meta-regression. JAMA. 2009;301(7):753–62.PubMedCrossRef de Boer AG, et al. Cancer survivors and unemployment: a meta-analysis and meta-regression. JAMA. 2009;301(7):753–62.PubMedCrossRef
4.
go back to reference Mehnert A. Employment and work-related issues in cancer survivors. Crit Rev Oncol Hematol. 2011;77(2):109–30.PubMedCrossRef Mehnert A. Employment and work-related issues in cancer survivors. Crit Rev Oncol Hematol. 2011;77(2):109–30.PubMedCrossRef
5.
go back to reference Taskila T, et al. Comparative study of work ability between cancer survivors and their referents. Eur J Cancer. 2007;43(5):914–20.PubMedCrossRef Taskila T, et al. Comparative study of work ability between cancer survivors and their referents. Eur J Cancer. 2007;43(5):914–20.PubMedCrossRef
6.
go back to reference Hansen JA, et al. Breast cancer survivors at work. J Occup Envrion Med. 2008;50(7):777–84.CrossRef Hansen JA, et al. Breast cancer survivors at work. J Occup Envrion Med. 2008;50(7):777–84.CrossRef
7.
go back to reference Hewitt M, et al. From Cancer Patient to Cancer Survivor: Lost in Translation. Institute of Medicine. Washington, DC: The National Academies Press; 2005. Hewitt M, et al. From Cancer Patient to Cancer Survivor: Lost in Translation. Institute of Medicine. Washington, DC: The National Academies Press; 2005.
8.
go back to reference Hassett MJ, O’Malley AJ, Keating NL. Factors influencing changes in employment among women with newly diagnosed breast cancer. Cancer. 2009;115(12):2775–82.PubMedCrossRef Hassett MJ, O’Malley AJ, Keating NL. Factors influencing changes in employment among women with newly diagnosed breast cancer. Cancer. 2009;115(12):2775–82.PubMedCrossRef
9.
go back to reference Bouknight RR, Bradley CJ, Luo Z. Correlates of return to work for breast cancer survivors. J Clin Oncol. 2006;24(3):345–53.PubMedCrossRef Bouknight RR, Bradley CJ, Luo Z. Correlates of return to work for breast cancer survivors. J Clin Oncol. 2006;24(3):345–53.PubMedCrossRef
10.
go back to reference Johnsson A, et al. Predictors of return to work ten months after primary breast cancer surgery. Acta Oncol. 2009;48(1):93–8.PubMedCrossRef Johnsson A, et al. Predictors of return to work ten months after primary breast cancer surgery. Acta Oncol. 2009;48(1):93–8.PubMedCrossRef
11.
go back to reference Johnsson A, et al. Work status and life changes in the first year after breast cancer diagnosis. Work. 2011;38(4):337–46.PubMed Johnsson A, et al. Work status and life changes in the first year after breast cancer diagnosis. Work. 2011;38(4):337–46.PubMed
12.
go back to reference Feuerstein M, et al. Work in cancer survivors: a model for practice and research. J Cancer Survivorship: Res Pract. 2010;4(4):415–37.CrossRef Feuerstein M, et al. Work in cancer survivors: a model for practice and research. J Cancer Survivorship: Res Pract. 2010;4(4):415–37.CrossRef
13.
go back to reference Thijs KM, et al. Rehabilitation using high-intensity physical training and long-term return-to-work in cancer survivors. J Occup Rehabil. 2012;22(2):220–9.PubMedCrossRef Thijs KM, et al. Rehabilitation using high-intensity physical training and long-term return-to-work in cancer survivors. J Occup Rehabil. 2012;22(2):220–9.PubMedCrossRef
14.
go back to reference Strauser D, et al. Vocational services associated with competitive employment in 18–25 year old cancer survivors. J Cancer Survivorship: Res Pract. 2010;4(2):179–86.CrossRef Strauser D, et al. Vocational services associated with competitive employment in 18–25 year old cancer survivors. J Cancer Survivorship: Res Pract. 2010;4(2):179–86.CrossRef
15.
go back to reference Shi Q, et al. Symptom burden in cancer survivors 1 year after diagnosis: a report from the American Cancer Society’s studies of cancer survivors. Cancer. 2011;117(12):2779–90.PubMedCrossRef Shi Q, et al. Symptom burden in cancer survivors 1 year after diagnosis: a report from the American Cancer Society’s studies of cancer survivors. Cancer. 2011;117(12):2779–90.PubMedCrossRef
16.
go back to reference Harrington CB, et al. It’s not over when it’s over: long-term symptoms in cancer survivors–a systematic review. Int J Psychiatry Med. 2010;40(2):163–81.PubMedCrossRef Harrington CB, et al. It’s not over when it’s over: long-term symptoms in cancer survivors–a systematic review. Int J Psychiatry Med. 2010;40(2):163–81.PubMedCrossRef
17.
go back to reference Heidrich SM, et al. An individualized representational intervention to improve symptom management (IRIS) in older breast cancer survivors: three pilot studies. Oncol Nurs Forum. 2009;36(3):E133–43.PubMedCrossRef Heidrich SM, et al. An individualized representational intervention to improve symptom management (IRIS) in older breast cancer survivors: three pilot studies. Oncol Nurs Forum. 2009;36(3):E133–43.PubMedCrossRef
18.
go back to reference Bradley CJ, et al. Employment and cancer: findings from a longitudinal study of breast and prostate cancer survivors. Cancer Invest. 2007;25(1):47–54.PubMedCrossRef Bradley CJ, et al. Employment and cancer: findings from a longitudinal study of breast and prostate cancer survivors. Cancer Invest. 2007;25(1):47–54.PubMedCrossRef
19.
go back to reference Bradley CJ, Bednarek HL. Employment patterns of long-term cancer survivors. Psychooncology. 2002;11(3):188–98.PubMedCrossRef Bradley CJ, Bednarek HL. Employment patterns of long-term cancer survivors. Psychooncology. 2002;11(3):188–98.PubMedCrossRef
20.
go back to reference Bradley CJ, et al. Employment outcomes of men treated for prostate cancer. J Natl Cancer Inst. 2005;97(13):958–65.PubMedCrossRef Bradley CJ, et al. Employment outcomes of men treated for prostate cancer. J Natl Cancer Inst. 2005;97(13):958–65.PubMedCrossRef
21.
go back to reference Spelten ER, et al. Cancer, fatigue and the return of patients to work-a prospective cohort study. Eur J Cancer. 2003;39(11):1562–7.PubMedCrossRef Spelten ER, et al. Cancer, fatigue and the return of patients to work-a prospective cohort study. Eur J Cancer. 2003;39(11):1562–7.PubMedCrossRef
22.
go back to reference Carlsen K, et al. Risk for unemployment of cancer survivors: a Danish cohort study. Eur J Cancer. 2008;44(13):1866–74.PubMedCrossRef Carlsen K, et al. Risk for unemployment of cancer survivors: a Danish cohort study. Eur J Cancer. 2008;44(13):1866–74.PubMedCrossRef
23.
go back to reference Sanchez KM, Richardson JL, Mason HR. The return to work experiences of colorectal cancer survivors. AAOHN J. 2004;52(12):500–10.PubMed Sanchez KM, Richardson JL, Mason HR. The return to work experiences of colorectal cancer survivors. AAOHN J. 2004;52(12):500–10.PubMed
24.
go back to reference Short PF, Vasey JJ, Tunceli K. Employment pathways in a large cohort of adult cancer survivors. Cancer. 2005;103(6):1292–301.PubMedCrossRef Short PF, Vasey JJ, Tunceli K. Employment pathways in a large cohort of adult cancer survivors. Cancer. 2005;103(6):1292–301.PubMedCrossRef
25.
go back to reference Tiedtke C, et al. Experiences and concerns about 'returning to work' for women breast cancer survivors: a literature review. Psychooncology. 2010;19(7):677–83.PubMed Tiedtke C, et al. Experiences and concerns about 'returning to work' for women breast cancer survivors: a literature review. Psychooncology. 2010;19(7):677–83.PubMed
26.
go back to reference Spelten ER, Sprangers MAG, Verbeek JHA. Factors reported to influence the return to work of cancer survivors: a literature review. Psycho-Oncology. 2002;11(2):124–31.PubMedCrossRef Spelten ER, Sprangers MAG, Verbeek JHA. Factors reported to influence the return to work of cancer survivors: a literature review. Psycho-Oncology. 2002;11(2):124–31.PubMedCrossRef
27.
go back to reference Maunsell E, et al. Work problems after breast cancer: an exploratory qualitative study. Psycho-Oncology. 1999;8(6):467–73.PubMedCrossRef Maunsell E, et al. Work problems after breast cancer: an exploratory qualitative study. Psycho-Oncology. 1999;8(6):467–73.PubMedCrossRef
28.
go back to reference Gaston-Johansson F, et al. Fatigue, pain, and depression in pre-autotransplant breast cancer patients. Cancer Pract. 1999;7(5):240–7.PubMedCrossRef Gaston-Johansson F, et al. Fatigue, pain, and depression in pre-autotransplant breast cancer patients. Cancer Pract. 1999;7(5):240–7.PubMedCrossRef
29.
go back to reference Fox SW, Lyon D. Symptom clusters and quality of life in survivors of ovarian cancer. Cancer Nurs. 2007;30(5):354–61.PubMedCrossRef Fox SW, Lyon D. Symptom clusters and quality of life in survivors of ovarian cancer. Cancer Nurs. 2007;30(5):354–61.PubMedCrossRef
30.
go back to reference Dodd MJ, Miaskowski C, Lee KA. Occurrence of symptom clusters. J Natl Cancer Inst Monogr. 2004;32:76–8.PubMedCrossRef Dodd MJ, Miaskowski C, Lee KA. Occurrence of symptom clusters. J Natl Cancer Inst Monogr. 2004;32:76–8.PubMedCrossRef
31.
go back to reference Given BA, et al. Symptom clusters and physical function for patients receiving chemotherapy. Semin Oncol Nurs. 2007;23(2):121–6.PubMedCrossRef Given BA, et al. Symptom clusters and physical function for patients receiving chemotherapy. Semin Oncol Nurs. 2007;23(2):121–6.PubMedCrossRef
32.
go back to reference Bower JE. Management of cancer-related fatigue. Clin Adv Hematol Oncol. 2006;4(11):828–9.PubMed Bower JE. Management of cancer-related fatigue. Clin Adv Hematol Oncol. 2006;4(11):828–9.PubMed
33.
go back to reference Bower JE. Prevalence and causes of fatigue after cancer treatment: the next generation of research. J Clin Oncol. 2005;23(33):8280–2.PubMedCrossRef Bower JE. Prevalence and causes of fatigue after cancer treatment: the next generation of research. J Clin Oncol. 2005;23(33):8280–2.PubMedCrossRef
34.
go back to reference Rietman JS, et al. Impairments, disabilities and health related quality of life after treatment for breast cancer: a follow-up study 2.7 years after surgery. Disabil Rehabil. 2004;26(2):78–84.PubMedCrossRef Rietman JS, et al. Impairments, disabilities and health related quality of life after treatment for breast cancer: a follow-up study 2.7 years after surgery. Disabil Rehabil. 2004;26(2):78–84.PubMedCrossRef
35.
go back to reference Fialka-Moser V, et al. Cancer rehabilitation: particularly with aspects on physical impairments. J Rehabil Med. 2003;35(4):153–62.PubMedCrossRef Fialka-Moser V, et al. Cancer rehabilitation: particularly with aspects on physical impairments. J Rehabil Med. 2003;35(4):153–62.PubMedCrossRef
36.
go back to reference Gordon LG, et al. The impact of rehabilitation support services on health-related quality of life for women with breast cancer. Breast Cancer Res Treat. 2005;93(3):217–26.PubMedCrossRef Gordon LG, et al. The impact of rehabilitation support services on health-related quality of life for women with breast cancer. Breast Cancer Res Treat. 2005;93(3):217–26.PubMedCrossRef
37.
go back to reference Norman SA, et al. Lymphedema in breast cancer survivors: incidence, degree, time course, treatment, and symptoms. J Clin Oncol. 2009;27(3):390–7.PubMedCrossRef Norman SA, et al. Lymphedema in breast cancer survivors: incidence, degree, time course, treatment, and symptoms. J Clin Oncol. 2009;27(3):390–7.PubMedCrossRef
38.
go back to reference Munir F, et al. Women’s perceptions of chemotherapy-induced cognitive side effects on work ability: a focus group study, in J Clin Nurs. 2010: England. p. 1362–70. Munir F, et al. Women’s perceptions of chemotherapy-induced cognitive side effects on work ability: a focus group study, in J Clin Nurs. 2010: England. p. 1362–70.
39.
go back to reference Calvio L, et al. Measures of cognitive function and work in occupationally active breast cancer survivors. J Occup Environ Med. 2010;52(2):219–27.PubMedCrossRef Calvio L, et al. Measures of cognitive function and work in occupationally active breast cancer survivors. J Occup Environ Med. 2010;52(2):219–27.PubMedCrossRef
40.
go back to reference Boykoff N, Moieni M, Subramanian SK. Confronting chemobrain: an in-depth look at survivors’ reports of impact on work, social networks, and health care response. J Cancer Surviv. 2009;3:223–32.PubMedCrossRef Boykoff N, Moieni M, Subramanian SK. Confronting chemobrain: an in-depth look at survivors’ reports of impact on work, social networks, and health care response. J Cancer Surviv. 2009;3:223–32.PubMedCrossRef
41.
go back to reference Oberst K, et al. Work task disability in employed breast and prostate cancer patients. J Cancer Surviv. 2010;4(4):322–30.PubMedCrossRef Oberst K, et al. Work task disability in employed breast and prostate cancer patients. J Cancer Surviv. 2010;4(4):322–30.PubMedCrossRef
42.
go back to reference de Boer AG, et al. Work ability and return-to-work in cancer patients. Br J Cancer. 2008;98(8):1342–7.PubMedCrossRef de Boer AG, et al. Work ability and return-to-work in cancer patients. Br J Cancer. 2008;98(8):1342–7.PubMedCrossRef
43.
go back to reference Drolet M, et al. Work absence after breast cancer diagnosis: a population-based study. CMAJ. 2005;173(7):765–71.PubMed Drolet M, et al. Work absence after breast cancer diagnosis: a population-based study. CMAJ. 2005;173(7):765–71.PubMed
44.
go back to reference Mols F, et al. Long-term cancer survivors experience work changes after diagnosis: results of a population-based study. Psychooncology, 2009. Mols F, et al. Long-term cancer survivors experience work changes after diagnosis: results of a population-based study. Psychooncology, 2009.
45.
47.
go back to reference Cleeland CS, et al. Assessing symptom distress in cancer patients: the M.D. Anderson Symptom Inventory. Cancer. 2000;89(7):1634–46.PubMedCrossRef Cleeland CS, et al. Assessing symptom distress in cancer patients: the M.D. Anderson Symptom Inventory. Cancer. 2000;89(7):1634–46.PubMedCrossRef
48.
go back to reference Fisch MJ, et al. Prospective, observational study of pain and analgesic prescribing in medical oncology outpatients with breast, colorectal, lung, or prostate cancer. J Clin Oncol. 2012;30(16):1980–8.PubMedCrossRef Fisch MJ, et al. Prospective, observational study of pain and analgesic prescribing in medical oncology outpatients with breast, colorectal, lung, or prostate cancer. J Clin Oncol. 2012;30(16):1980–8.PubMedCrossRef
49.
go back to reference Tevaarwerk A, et al. Predictors of employment outcomes in breast cancer (BrCa) patients: an analysis from E2Z02 (ECOG’s SOAPP study). in San Antonio Breast Cancer Symposium (abstract). 2010. Tevaarwerk A, et al. Predictors of employment outcomes in breast cancer (BrCa) patients: an analysis from E2Z02 (ECOG’s SOAPP study). in San Antonio Breast Cancer Symposium (abstract). 2010.
50.
go back to reference Palos GR, et al. Asking the community about cutpoints used to describe mild, moderate, and severe pain. J Pain: J Am Pain Soc. 2006;7(1):49–56.CrossRef Palos GR, et al. Asking the community about cutpoints used to describe mild, moderate, and severe pain. J Pain: J Am Pain Soc. 2006;7(1):49–56.CrossRef
51.
go back to reference Serlin RC, et al. When is cancer pain mild, moderate or severe? Grading pain severity by its interference with function. Pain. 1995;61(2):277–84.PubMedCrossRef Serlin RC, et al. When is cancer pain mild, moderate or severe? Grading pain severity by its interference with function. Pain. 1995;61(2):277–84.PubMedCrossRef
52.
go back to reference Jeon S, et al. Do interference-based cut-points differentiate mild, moderate, and severe levels of 16 cancer-related symptoms over time? J Pain Symptom Manag. 2009;37(2):220–32.CrossRef Jeon S, et al. Do interference-based cut-points differentiate mild, moderate, and severe levels of 16 cancer-related symptoms over time? J Pain Symptom Manag. 2009;37(2):220–32.CrossRef
53.
go back to reference Selby D, et al. A single set of numerical cutpoints to define moderate and severe symptoms for the Edmonton Symptom Assessment System. J Pain Symptom Manag. 2010;39(2):241–9.CrossRef Selby D, et al. A single set of numerical cutpoints to define moderate and severe symptoms for the Edmonton Symptom Assessment System. J Pain Symptom Manag. 2010;39(2):241–9.CrossRef
54.
go back to reference Zeger SL, Liang KY. Longitudinal data analysis for discrete and continuous outcomes. Biometrics. 1986;42(1):121–30.PubMedCrossRef Zeger SL, Liang KY. Longitudinal data analysis for discrete and continuous outcomes. Biometrics. 1986;42(1):121–30.PubMedCrossRef
55.
go back to reference Hardin J, Hilbe J, editors. Generalized estimating equations. Boca Raton: Chapman & Hall/CRC; 2003. Hardin J, Hilbe J, editors. Generalized estimating equations. Boca Raton: Chapman & Hall/CRC; 2003.
57.
go back to reference Johnsson A, et al. Factors associated with return to work after breast cancer treatment. Acta Oncologica. 2007;46(1):90–6.PubMedCrossRef Johnsson A, et al. Factors associated with return to work after breast cancer treatment. Acta Oncologica. 2007;46(1):90–6.PubMedCrossRef
58.
go back to reference Ramsey S, et al. Cancer diagnosis as a risk factor for personal bankruptcy. 2011. J Clin Oncol 29:385s (suppl; abstr 6007). Ramsey S, et al. Cancer diagnosis as a risk factor for personal bankruptcy. 2011. J Clin Oncol 29:385s (suppl; abstr 6007).
59.
go back to reference Ahn E, et al. Impact of breast cancer diagnosis and treatment on work-related life and factors affecting them. Breast Cancer Res Treat. 2009;116(3):609–16.PubMedCrossRef Ahn E, et al. Impact of breast cancer diagnosis and treatment on work-related life and factors affecting them. Breast Cancer Res Treat. 2009;116(3):609–16.PubMedCrossRef
60.
go back to reference Verbeek J, et al. Return to work of cancer survivors: a prospective cohort study into the quality of rehabilitation by occupational physicians. Occup Environ Med. 2003;60(5):352–7.PubMedCrossRef Verbeek J, et al. Return to work of cancer survivors: a prospective cohort study into the quality of rehabilitation by occupational physicians. Occup Environ Med. 2003;60(5):352–7.PubMedCrossRef
61.
go back to reference Yancik R, et al. Effect of age and comorbidity in postmenopausal breast cancer patients aged 55 years and older. JAMA. 2001;285(7):885–92.PubMedCrossRef Yancik R, et al. Effect of age and comorbidity in postmenopausal breast cancer patients aged 55 years and older. JAMA. 2001;285(7):885–92.PubMedCrossRef
62.
go back to reference de Boer AGEM, Frings-Dresen MHW. Employment and the common cancers: return to work of cancer survivors. Occup Med. 2009;59(6):378–80.CrossRef de Boer AGEM, Frings-Dresen MHW. Employment and the common cancers: return to work of cancer survivors. Occup Med. 2009;59(6):378–80.CrossRef
63.
go back to reference Bradley CJ, et al. Short-term effects of breast cancer on labor market attachment: results from a longitudinal study. J Health Econ. 2005;24(1):137–60.PubMedCrossRef Bradley CJ, et al. Short-term effects of breast cancer on labor market attachment: results from a longitudinal study. J Health Econ. 2005;24(1):137–60.PubMedCrossRef
64.
go back to reference Hansen A, Edlund C, Henningsson M. Factors relevant to a return to work: a multivariate approach. Work. 2006;26(2):179–90.PubMed Hansen A, Edlund C, Henningsson M. Factors relevant to a return to work: a multivariate approach. Work. 2006;26(2):179–90.PubMed
65.
go back to reference Purdie F, Kellett S, Bickerstaffe D. Predictors of Functional Disability in Disability Welfare Claimants. J Occup Rehab, 2012 (Epub). Purdie F, Kellett S, Bickerstaffe D. Predictors of Functional Disability in Disability Welfare Claimants. J Occup Rehab, 2012 (Epub).
66.
go back to reference Stewart CM, et al. Salivary dysfunction and quality of life in Sjogren syndrome: a critical oral-systemic connection. J Am Dent Assoc. 008;139(3):291–9. quiz 358–9. Stewart CM, et al. Salivary dysfunction and quality of life in Sjogren syndrome: a critical oral-systemic connection. J Am Dent Assoc. 008;139(3):291–9. quiz 358–9.
67.
go back to reference Molassiotis A, Rogers M. Symptom experience and regaining normality in the first year following a diagnosis of head and neck cancer: A qualitative longitudinal study. Palliative Supportive Care, 2012;1–8. Molassiotis A, Rogers M. Symptom experience and regaining normality in the first year following a diagnosis of head and neck cancer: A qualitative longitudinal study. Palliative Supportive Care, 2012;1–8.
68.
go back to reference Perez EA. Safety of aromatase inhibitors in the adjuvant setting. Breast Cancer Res Treat. 2007;105 Suppl 1:75–89.PubMedCrossRef Perez EA. Safety of aromatase inhibitors in the adjuvant setting. Breast Cancer Res Treat. 2007;105 Suppl 1:75–89.PubMedCrossRef
69.
go back to reference Chambers MS, et al. Radiation-induced xerostomia in patients with head and neck cancer: pathogenesis, impact on quality of life, and management. Head Neck. 2004;26(9):796–807.PubMedCrossRef Chambers MS, et al. Radiation-induced xerostomia in patients with head and neck cancer: pathogenesis, impact on quality of life, and management. Head Neck. 2004;26(9):796–807.PubMedCrossRef
70.
go back to reference Rowland J, et al. Cancer survivorship—United States, 1971–2001. MMWR. 2004;53:526–9. Rowland J, et al. Cancer survivorship—United States, 1971–2001. MMWR. 2004;53:526–9.
71.
go back to reference de Boer AGEM, et al. Interventions to enhance return-to-work for cancer patients. Cochrane Database Syst Rev. 2011 Feb 16;(2):CD007569 de Boer AGEM, et al. Interventions to enhance return-to-work for cancer patients. Cochrane Database Syst Rev. 2011 Feb 16;(2):CD007569
Metadata
Title
Employment outcomes among survivors of common cancers: the Symptom Outcomes and Practice Patterns (SOAPP) study
Authors
A. J. Tevaarwerk
J. W. Lee
M. E. Sesto
K. A. Buhr
C. S. Cleeland
J. Manola
L. I. Wagner
V. T. S. Chang
M. J. Fisch
Publication date
01-06-2013
Publisher
Springer US
Published in
Journal of Cancer Survivorship / Issue 2/2013
Print ISSN: 1932-2259
Electronic ISSN: 1932-2267
DOI
https://doi.org/10.1007/s11764-012-0258-2

Other articles of this Issue 2/2013

Journal of Cancer Survivorship 2/2013 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine